Showing posts with label Mutations. Show all posts
Showing posts with label Mutations. Show all posts

Thursday, April 2, 2020

ANTIBIOTIC RESISTANCE - Bacteria are prone to DNA mutations. This is part of their natural evolution and allows them to constantly adapt their genetic makeup. What if nothing happens the next time you pop one of those little bug-busting pills? Your life could be in serious danger. The WHO call antibiotic resistance ‘one of the biggest threats to global health.’ Bacteria are an integral part of our ecosystem and we share our bodies with many of these tiny creatures. However, they can be the root of serious health problems. There are roughly as many human cells as bacterial cells in our bodies, and our microscopic passengers pay their way by helping our immune system and contributing to our metabolism. But bacteria come in all manner of guises. Some can turn from friend to foe, while others are just plain nasty and will make us sick at any chance they get. Since their discovery in the 1920s and their introduction into mainstream medicine after World War Two, we’ve been relying on antibiotics to keep pathogenic bacteria at bay. Antibacterial resistance is on the rise, however. Bacteria are prone to DNA mutations. This is part of their natural evolution and allows them to constantly adapt their genetic makeup. When one bug naturally becomes resistant to a drug, it survives when all others are killed. Now it’s a race against the clock.

Antimicrobial resistance and the role of vaccines | PNAS
.............................................................................................................................................................
Antibiotic resistance: What causes it?Antibiotic Resistance
What causes antibiotic resistance?
What Is Antibiotic Resistance? A Look at This Issue : Medical Blog ...Bacteria are prone to DNA mutations. This is part of their natural evolution and allows them to constantly adapt their genetic makeup - when one bug naturally becomes resistant to a drug, it survives when all others are killed

Written by Yella Hewings-Martin, Ph.D.
Fact checked by Jasmin Collier


Most of us will have taken antibiotics at some point in our lives.
But what if nothing happens the next time you pop one of those little bug-busting pills? Your life could be in serious danger.
The WHO call antibiotic resistance ‘one of the biggest threats to global health.’
Bacteria are an integral part of our ecosystem and we share our bodies with many of these tiny creatures. However, they can be the root of serious health problems.
Antibiotic Resistance: What Are Superbugs & How Can We Fight Them ...There are roughly as many human cells as bacterial cells in our bodies, and our microscopic passengers pay their way by helping our immune system and contributing to our metabolism.
But bacteria come in all manner of guises. Some can turn from friend to foe, while others are just plain nasty and will make us sick at any chance they get.
Since their discovery in the 1920s and their introduction into mainstream medicine after World War Two, we’ve been relying on antibiotics to keep pathogenic bacteria at bay.
Antibacterial resistance is on the rise, however.
According to the Centers for Disease Control and Prevention (CDC), each year in the United States, at least 2,049,442 illnesses are caused by resistance to medicines prescribed to treat bacterial or fungal infections.
What is more, 23,000 people die each year when these drugs fail to work.
So, why have our once reliable antibacterials stopped working, and how do the pesky bugs manage to outfox us? It’s all about mutations.
Mutations, a ‘natural phenomenon’
Bacteria are prone to DNA mutations. This is part of their natural evolution and allows them to constantly adapt their genetic makeup.
When one bug naturally becomes resistant to a drug, it survives when all others are killed.
Now it’s a race against the clock.
How quickly can this one bacterium adapt to the new mutation, and how quickly can it replicate in the face of species eradication?
If the bug comes on out top, it’s bad news for the infected individual and bad news for society at large: the drug-resistant bacterium will likely spread.
Not only has it evaded the grim reaper, but it can also now spread the love by passing the resistance to its numerous offspring, who will soon be the dominant species on the block.
Bacteria are also able to pass genes to other bacteria. This is known as horizontal gene transfer, or “bacterial sex.”
While this process is actually quite rare, bacteria are highly mobile creatures, which gives them plenty of opportunity to come into contact with other microbes and pass on their mutated genes.
But how do genetic mutations equip bacteria with the skills to outsmart antibiotics?
Combating antibiotics
A study recently published in Nature Communications sheds new light on how Echerichia coli and other members of the Enterobacteria family fight off commonly used antibiotics.
A gene called mar is commonly shared by family members.
Some of the proteins encoded in this gene can switch on other genes, explain researchers from the University of Birmingham’s Institute of Microbiology and Infection in the United Kingdom.
“We found two completely unexpected mechanisms,” says senior study author Prof. David Grainger, “that bacteria use to protect themselves from antibiotics. One protected their DNA from the harmful effects of fluoroquinolone antibiotics, and the other prevented doxycyline getting inside bacteria.”
But finding out how Enterobacteria combat antibiotics is only the first step in this decade-long research project.
First study author Prateek Sharma, Ph.D., says that “the resistance mechanisms that we identified are found in many different species of bacteria therefore, our research could lead to the discovery of molecules that could be developed into new drugs that can treat bacterial infections.”
The World Health Organization (WHO) call antibiotic resistance “one of the biggest threats to global health, food security, and development today.”
The need for new drugs is great.
‘Overuse and underuse’ of antibiotics
This week is World Antibiotic Awareness Week. The WHO aim to warn people that inappropriate use of antimicrobials makes drug resistance worse. This includes both overuse and underuse.
This year, they urge everyone to “[s]eek advice from a qualified healthcare professional before taking antibiotics.”
To find out more, here is video from the WHO explaining why they think that “everyone has a role to play to help reduce antibiotic resistance.”

Medical News Today, part of Healthline Media UK, is one of the fastest growing health information sites in the United States. Every month, more than 70 million people come to Medical News Today for our in-depth health content and the latest news in medical research. Consider us your intellectual peer. We unravel the complexities of health information and make it easy to understand.
We take a deep dive into medical research of the past and present, and we break it down to give you the clear-cut facts. Ultimately, we want you to be confident in making informed health decisions for yourself and your loved ones. Using peer reviewed studies and reputable sources, our knowledgeable and curious editors and writers create more than 250 pieces of content every month.
Stay up to date on the latest health news by subscribing to our newsletter or following Medical News Today on Twitter, Facebook, or Instagram.
Antibiotic Resistance and Us [Infographic] - Health Care News and ...

Monday, December 2, 2019

CHILDREN AND LEUKEMIA - Leukemia, which disrupts normal cell growth in the blood and bone marrow, accounts for nearly one-third of all childhood cancer cases. Certain forms of leukemia tend to strike early in life and affect far more children than adults. The disease manifests in various forms, and the subtypes that mostly affect children typically progress quickly and require immediate, aggressive treatment. Although similarities exist between childhood and adult leukemias, evidence suggests that the cancers don't share the same genetic roots. What has been known for some time is that there are clear genetic differences between childhood cancer and adult cancer. Important distinctions between childhood and adult leukemia may lie in how the bone marrow functions in people of different ages and how cancer commandeers that tissue for its own purposes.

Chemotherapy treatment
................................................................................................................................................................
Children And Leukemia
Why Do Some Forms of Leukemia Affect Mostly Children?
By Nicoletta Lanese - Staff Writer 




Childhood leukemias may exploit specific vulnerabilities found only in immature cells.
Certain forms of leukemia tend to strike early in life and affect far more children than adults.          
Leukemia, which disrupts normal cell growth in the blood and bone marrow, accounts for nearly one-third of all childhood cancer cases, according to the American Cancer Society (ACS).
The disease manifests in various forms, and the subtypes that mostly affect children typically progress quickly and require immediate, aggressive treatment.
Although similarities exist between childhood and adult leukemias, evidence suggests that the cancers don't share the same genetic roots.                   
"What has been known for some time is that there are clear genetic differences between childhood cancer and adult cancer," said Dr. Thomas Mercher, a director of hematology-oncology research for the French National Institute of Health and Medical Research and the Gustave Roussy research institute in Villejuif, France.
Studies suggest that the specific genetic quirks seen in childhood leukemia cells may arise very early in life, or even in the womb, but how this happens step by step "is generally very unclear," Mercher said. 
Now, new research hints that childhood leukemia may be able to hijack only young, developing cells — like those found in fetuses and children — not the mature cells of full-grown adults. 
/
To investigate why certain leukemias may prey on immature cells, Mercher and his colleagues gathered genetic samples from young patients with a particularly aggressive form of acute myeloid leukemia (AML) and replicated the disease in mouse models.
The team's study, published Oct. 29 in the journal Cancer Discovery, hints at why the cancer appears early in life, often before the affected child reaches 2 years old.
"The genetic alterations that we studied here are only found in childhood leukemia," Mercher added. 
In general, AML is more prevalent in adults than children; the disease accounts for fewer than 25% of all childhood leukemia cases, according to the American Cancer Society.
However, a rare subtype called "acute myeloblastic leukemia type 7" (AML-M7) predominantly appears in infants under the age of 2.
Children with other forms of AML develop the disease later in life, around age 6, and show better survival rates than individuals with the more-aggressive subtype, the authors noted in a statement. 
Could the children's ages at the time of disease onset offer clues as to why these cancers have such different outcomes? To find out, the researchers looked to the children's genes.     
Frankenstein-style mutations 
Back in 2012, the team gathered leukemia cells from both children and adults who had AML-M7, discovering a key difference between the genetic material in the children versus the adults.
Many of the children's cells contained genes that had merged together, Frankenstein-style, to form new, hybrid genes.
Individually, the genes play important roles in blood cell development, but once stuck together, those genes may direct cells to build unusual proteins and ultimately transform into cancerous cells, the researchers theorized.
None of these "fusion genes" appeared in a single adult leukemia cell, which hinted that the team might be onto something.      
After the researchers published this initial finding, they and other scientists found ample evidence of fusion genes in AML-M7 leukemia.
But no one knew exactly what these hybrid genes did or why they appeared only in children. 
So, Mercher and his colleagues continued to investigate, focusing their research on a fusion gene known as ETO2–GLIS2.
Welding together two normally separate genes, ETO2 and GLIS2, the mutation appears in about 30% of children with AML-M7 and seems linked to poor responses to cancer treatment and low survival rates, the researchers wrote.
To learn how this mutation drives cancer, the team observed how the fusion gene seized control of hematopoietic stem cells, cells that normally give rise to healthy blood cells but can get hijacked by leukemia.          
The scientists developed a mouse model in which they could turn the ETO2–GLIS2 mutation "on" or "off" in a given tissue inside the mouse.
They ran their experiment in both fetal and adult-age mice to see if the fusion gene would affect cells differently depending on the cells' stage of development.
Turns out, that's exactly what happened. When the team activated ETO2–GLIS2 in fetal stem cells, the resulting proteins seemed to tamper with cellular pathways that normally turn the cells into healthy blood cells.
Basically, the fusion gene flipped a "molecular switch" that rapidly transformed the stem cells into aggressive leukemia.
Blocking ETO2–GLIS2 activation in the same fetal mice flipped the switch back, curbed the cancer growth and allowed stem cells to turn into normal blood once more. 
By comparison, the adult stem cells appeared "much less prone to give rise to leukemia" when ETO2–GLIS2 was activated, Mercher said.
In fact, the fusion gene did not appear to be a key driver of leukemia progression in adult mice. 
"The developmental stage of the cells in which the mutation arises determines the aggressiveness and the type of leukemia that you get," Mercher said. 
/
The results "show that more people should be paying attention to the fetal bone marrow environment," where hematopoietic stem cells can be found, said Dr. Mignon Loh, a pediatric hematologist-oncologist at the University of California, San Francisco, who was not involved in the study.
The immediate environment, or niche, where a fetal stem cell develops looks very different from the environment surrounding an adult cell, she said. 
"When you're a baby and have been incubating for 9 months, that niche is pretty pure," Loh said. Important distinctions between childhood and adult leukemia may lie in how the bone marrow functions in people of different ages and how cancer commandeers that tissue for its own purposes, she said. 
Research into ETO2–GLIS2 may also shed light on how other forms of childhood leukemia rely on fusion genes, provided that the team's findings in mice hold true in humans, Loh said.
More broadly, further research into the nature of fetal stem cells in general could reveal other avenues by which leukemia exploits developing cells, she said.
"There may be something permissive about a fetal-like stem cell" that allows it to transform into malignant cancer, Loh said.
If future research could pinpoint how child-specific mutations cause leukemia, drugs could be developed to stall or stop the disease, Mercher added. 
"That would be like [finding] the holy grail," Loh said.

Nicoletta Lanese is a science journalist and dancer who aims to bring science to new audiences, whether in print or on stage. She holds degrees in neuroscience and dance from the University of Florida and a graduate certificate in science communication from the University of California, Santa Cruz. Brains are her beat. Follow her on Twitter @NicolettaML. 
Chemotherapy treatment